Zai Lab Obtains Breakthrough Therapy Designation for Efgarti

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National

Related Keywords

China , Cambridge , Cambridgeshire , United Kingdom , Shanghai , Macau , Hong Kong , United States , Taiwan , Chinese , Harald Reinhart , Jennifer Chang Xiaoyu Chen , Christine Chiou Lina Zhang , National Medical Products Administration , Zai Lab Limited , Head Of Global Development , Zai Lab , Zai Lab Forward , China International Nonproprietary Name , Exchange Commission , Lab Limited , Drug Evaluation , Breakthrough Therapy Designation , Global Development , Infectious Diseases , Greater China , Private Securities Litigation Reform Act , Region ,